{"nct_id":"NCT03930732","title":"Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2019-04-15","start_date_type":"ACTUAL","primary_completion_date":"2023-02-08","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-02","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}